From our findings, by replacing AFP-related DNA aptamer with a variety of other diseases-involving aptamers, this sensor technology development strategy as a model can operate in the detection of their biomarkers as well as in the clinical diagnoses of their corresponding diseases, especially other cancers. Here, AFP is linked to cancer.